A recent benchmarking study examines best practices in pharmaceutical launches, and includes case studies and insights from some of the industry’s biggest companies.The study, performed by Best Practices LLC, includes best practices from Merck & Co., Eli Lilly & Co., Wyeth, GlaxoSmithKline Inc., Novartis, Johnson & Johnson and AstraZeneca. “Best Practices in Global Pharmaceutical Launches” includes:

• Analysis of the multiyear marketing launch investment and expense patterns of successful products
• Profiles of leading pharmaceutical companies’ approaches to structuring global marketing organizations
• Identification of best management practices employed during key launch activities
• Key lessons learned in planning and coordinating successful global product launches

The leading practices, managerial insights and benchmark metrics in the report are drawn from in-depth surveys and interviews with more than 26 executives at leading pharmaceutical companies. The project team used the launches of 12 pharmaceutical products, including Zoloft, Paxil, Cardizem, Fosamax and Lipitor, to illustrate some of the problems the companies faced.

For more information, visit www3.best-in-class.com.

 …